ArticleActa dermato-venereologica2025

Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors.

Christopher Willy Schwarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.